
Sign up to save your podcasts
Or


Jim Cramer and David Faber discuss Wall Street’s tough September, stocks on pace for their fourth straight weekly loss, for the first time in more than a year. Plus signs of hope for a COVID-19 vaccine, Novavax starting a phase 3 trial & Sanofi predicting one billion doses produced globally by early next year. And House Democrats preparing a new $2.4 trillion stimulus plan with unemployment aid, direct payments.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.1
542542 ratings
Jim Cramer and David Faber discuss Wall Street’s tough September, stocks on pace for their fourth straight weekly loss, for the first time in more than a year. Plus signs of hope for a COVID-19 vaccine, Novavax starting a phase 3 trial & Sanofi predicting one billion doses produced globally by early next year. And House Democrats preparing a new $2.4 trillion stimulus plan with unemployment aid, direct payments.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,093 Listeners

3,228 Listeners

1,381 Listeners

242 Listeners

152 Listeners

532 Listeners

323 Listeners

68 Listeners

153 Listeners

1,047 Listeners

33 Listeners

353 Listeners

45 Listeners

2,155 Listeners

5 Listeners

567 Listeners

20 Listeners

1,576 Listeners

215 Listeners

410 Listeners

302 Listeners

121 Listeners

827 Listeners

169 Listeners

35 Listeners

12 Listeners

50 Listeners

28 Listeners

8 Listeners

16 Listeners

0 Listeners